Audience: Patients and the public. Published 20 November 2026 (AEDT). Therapeutic Goods Administration (TGA) review outcomes published 16 October 2026.

Many GPs and other clinicians now use “AI scribes”: software that listens to a consultation and drafts the clinical notes or letters. Australia’s medicines and devices regulator, the TGA, has published the results of a review of these tools. It found that some of them now do more than take notes, and that some functions may need to be regulated as medical devices.

What the TGA found

The TGA identified about 100 suppliers of digital scribes in Australia and looked closely at 12 products, including some of the most widely used. None of the 12 suppliers described their product as a medical device. The TGA judged that 8 of the 12 included functions likely to meet the definition of a medical device, 2 needed more information, and 2 appeared unlikely to be medical devices. The report did not say which finding applied to which product.

The difference comes down to what the software does. A scribe that only records, transcribes and summarises what was said is generally treated as an administrative tool. A scribe that suggests diagnoses, treatments or tests, or ranks which patients need attention first, is likely to be a medical device and would need to meet medical device rules. The TGA says it will provide more guidance and take targeted, proportionate compliance action where needed.

What this may mean for you

  • The review does not say AI scribes are unsafe, and it does not ban them. The TGA did not test how accurate or safe any product is.
  • The RACGP advises GPs to ask for your consent before using an AI scribe at the start of each consultation. You can decline.
  • It is reasonable to ask how the recording or transcript is stored, and for how long.
  • Your doctor remains responsible for your health record. The RACGP advises GPs to check AI-generated notes for accuracy, because these tools can make errors.

How common are AI scribes?

In a recent online poll of newsGP readers (the RACGP’s news service), 49% of 1,114 respondents said they use an AI scribe, up from 22% in 2024 and 40% in 2025. This was a voluntary readers’ poll, so it may not reflect all GPs in Australia.

Limitations

The TGA review was based on product documentation, marketing material and a voluntary supplier survey (40 of about 100 suppliers responded). It did not test products, check their safety or performance, or assess privacy and data protection. It does not tell you whether the scribe used at any particular clinic is a medical device.

Prepared with AI assistance from the linked sources; not individually reviewed by a clinician. General information only, not individual medical or legal advice. If you have questions about how your consultation is recorded, ask your clinic.

Sources

TGA: Digital scribe review outcomes, 16 October 2026 (accessed 20 November 2026, AEDT).
TGA: Digital scribes – when digital scribes are regulated as medical devices, last updated 16 October 2026 (accessed 20 November 2026, AEDT).
RACGP: Artificial intelligence (AI) scribes fact sheet, last updated October 2025 (accessed 20 November 2026, AEDT).
RACGP newsGP: Almost half of GPs now using AI scribes as adoption climbs, 12 November 2026 (accessed 20 November 2026, AEDT).